探讨超声引导下经皮聚桂醇治疗不同大小腹、盆腔囊性病变的治疗疗效及其安全性。

选取2012年12月至2014年12月在山西煤炭中心医院就诊的腹、盆腔囊性病变患者76例，其中肝囊肿23例、肾囊肿16例、卵巢巧克力囊肿23例、子宫切除术后淋巴囊肿8例及盆腔包裹性积液6例。所有患者均行超声引导下腹、盆腔囊性病变聚桂醇硬化剂治疗。按病变大小分为囊肿最大径≥8 cm组（29例）与囊肿最大径<8 cm组（47例）。同时观察治疗的不良反应及安全性。治疗后3个月、6个月及12个月超声随访观察治疗疗效，囊肿完全消失为治愈，囊肿较治疗前体积缩小程度大于75%但未完全消失为有效。

聚桂醇治疗腹、盆腔囊性病变效果明显，治疗后3个月及6个月治疗总有效率分别达96.1%及100%；治疗后12个月治愈率达100%。治疗后3个月及6个月，囊肿最大径<8 cm组疗效明显优于囊肿最大径≥8 cm组（χ²=18.86、9.80，P均<0.01）。2组间不良反应发生率无显著差异（P=0.893）。

超声引导下经皮聚桂醇治疗腹、盆腔囊性病变简便易行，疗效显著，安全性好，不良反应少；对于囊肿病变较大者，长期疗效也较为理想，值得临床推广应用。

To assess the therapeutic effects and safety of ultrasound-guided percutaneous lauromacrogol injection therapy for abdominal and pelvic cystic lesions with different sizes.

Twenty-three cases of hepatic cysts, 16 cases of renal cysts, 23 cases of endometrial cysts of the ovary, 8 cases of lymphatic cysts after uterectomy and 6 cases of pelvic fluid collections were included in this study. All the patients were treated at the Shanxi Coal Center Hospital from December 2012 to December 2014 using ultrasound-guided percutaneous sclerosing lauromacrogol injection therapy. The lesions were grouped as a cyst diameter≥8 cm group and a cyst diameter<8 cm group. The side effects and safety were observed. The therapeutic effects was observed and evaluated using conventional ultrasound 3, 6 and 12 months after treatment. The cyst was considered cured if it completely disappeared and effective if it shrank more than 75% in volume but did not completely disappeared.

The therapeutic effects of sclerosing lauromacrogol injection therapy for abdominal and pelvic cystic lesions were significant, with a total effective rate of 96.1% and 100%, respectively, at 3 and 6 months after treatment. The cure rate was 100% at 12 months after treatment. The therapeutic effects at 3 and 6 months for the cyst diameter<8 cm group were significantly higher than those for the cyst diameter≥8 cm group (P<0.01). The rates of adverse effects had no significant difference between the two groups (P<0.01).

Ultrasound-guided percutaneous lauromacrogol injection therapy for abdominal and pelvic cystic lesions is a simple, convenient, feasible, and effective method with little side effects.